Study ID: CA43-I7P-MC-DSAF for Hidradenitis Suppurativa
Summary
The main goal of this study is to
see if a new investigational drug improves the lumps and pain associated with HS.
Antibiotics and other treatments often aren’t
enough to help HS. With your participation,
we hope to find a better way to treat this
painful condition. The main goal of this
study is to see if a new investigational drug improves the lumps and
pain associated with HS.
Research studies (also referred to as clinical trials or clinical studies) help doctors learn more about what a specific treatment does in people with a specific health condition,
how safe that treatment is, and whether it can help people with that condition.
Our country’s healthcare authorities require well-thought-out research studies to be conducted before a new drug, vaccine or medical device can be approved for doctors to prescribe to people as part of routine medical practice.
Inclusion Criteria
Participants are eligible to be included in the study only if all of the following criteria apply:
1. The participant must be 18 or the legal age of consent in the jurisdiction
in which the study is taking place to 75 years of age, inclusive, at the time
of signing the informed consent form.
2. Participants who have a diagnosis of HS for at least 12 months before
randomization (Visit 2).
3. Have HS lesions in at least two distinct anatomical regions. At least one of the lesions must be at
least Hurley Stage II or III.
4. Had an inadequate response or intolerance to a 28-day course of oral
antibiotics at any time before screening.
5. Have a total abscess and inflammatory nodule count greater than or equal
to 5 at both screening (Visit 1) and randomization (Visit 2)
Contact us about joining the trial
To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.
Fill out this form to get in touch. We will contact you in 1-2 business days regarding your application to participate in the trial. You can also call us at #(289)-763-8666
Privacy Policy for SimcoDerm Clinical Trials
Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.
We collect information directly from you, including your name, contact details, health information, and treatment history.
We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.
Data Protection:
Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.
You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.